Endoscopic management of primary sclerosing cholangitis
Digestive Endoscopy · 2025
DOI: 10.1111/den.15010 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Digestive Endoscopy, 2025. Verfasst von Suguru Mizuno und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gastroenterology and Hepatology, Faculty of Medicine, Saitama Medical University, Saitama, Japan. Hauptthemen laut MEDLINE: Cholangitis, Sclerosing, Cholangiopancreatography, Endoscopic Retrograde, Endosonography. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 48 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Primary sclerosing cholangitis (PSC) is a progressive autoimmune hepatobiliary disease characterized by fibrotic strictures in the bile ducts, leading to chronic cholestasis and cirrhosis. Magnetic resonance cholangiopancreatography (MRCP) is a noninvasive method for evaluating the condition of the bile ducts, and has high sensitivity and specificity, making it the first‐line diagnostic tool for PSC. However, the importance of endoscopic retrograde cholangiopancreatography (ERCP) remains unchanged. ERCP is particularly useful in differentiating PSC from cholangiocarcinoma. It allows for tissue sampling from strictures and offers superior spatial resolution to detect subtle changes in the bile ducts. Endoscopic ultrasonography (EUS) is a minimally invasive endoscopic modality with growing importance in the management of pancreato‐biliary diseases. Although the role of EUS in PSC patients has not been established, future research in this area is warranted. ERCP is particularly important for patients who are not eligible for liver transplantation, as it allows bile drainage from the dominant or high‐grade strictures through balloon dilation and stenting, alleviating symptoms and extending survival. Balloon dilation is currently considered superior to biliary stenting, due to its lower risk of bacterial cholangitis. However, refractory complications, such as bacterial cholangitis and pancreatitis, can still occur in some cases. Therefore, careful patient selection and involvement of highly skilled specialists are essential. In the diagnosis and treatment of PSC, it is crucial to perform endoscopic procedures tailored to its unique pathophysiology. Further research is needed to optimize treatment protocols and improve outcomes. This review presents the latest insights on these topics.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Gastroenterology and Hepatology, Faculty of Medicine, Saitama Medical University, Saitama, Japan.
ORCID-Profile: Suguru Mizuno, Yoshihito Uchida
Zitieren
APA
Mizuno, S., Uchida, Y., Ando, S., Nakao, M., Sugawara, K., Nakayama, N., Imai, Y., Tomiya, T., & Mochida, S. (2025). Endoscopic management of primary sclerosing cholangitis. Digestive Endoscopy. https://doi.org/10.1111/den.15010
Vancouver
Mizuno S, Uchida Y, Ando S, Nakao M, Sugawara K, Nakayama N, et al. Endoscopic management of primary sclerosing cholangitis. Digestive Endoscopy. 2025. doi:10.1111/den.15010
BibTeX
@article{Mizuno2025,
author = {Mizuno, Suguru and Uchida, Yoshihito and Ando, Satsuki and Nakao, Masamitsu and Sugawara, Kayoko and Nakayama, Nobuaki and Imai, Yukinori and Tomiya, Tomoaki and Mochida, Satoshi},
title = {Endoscopic management of primary sclerosing cholangitis},
journal = {Digestive Endoscopy},
year = {2025},
doi = {10.1111/den.15010}
}
EUVIMED